Table 3.
Disease-free survival | Overall survival | |||||
---|---|---|---|---|---|---|
HR | 95% Cl | P value | HR | 95% CI | P value | |
R2 value | 0.178 | 0.044–0.722 | 0.016 | 0.154 | 0.043–0.555 | 0.004 |
R2(triple) | ||||||
0.9–1.0 (group 1) | 3.121 | 1.140–8.542 | 0.027 | 3.812 | 1.555–9.347 | 0.003 |
0.5–1.0 (group 2) | 1.454 | 0.567–3.728 | 0.436 | 1.355 | 0.532–3.451 | 0.141 |
0.3–0.5 (group 3) | 1 | 1 | ||||
R2 (cutoff) | ||||||
0.9–1.0 (group I) | 1.720 | 0.795–3.719 | 0.168 | 2.111 | 1.021–4.366 | 0.044 |
0.3–0.9 (group II) | 1 | 1 | ||||
Gradient (value “q”) | 0.527 | 0.156–1.778 | 0.302 | 0.551 | 0.175–1.736 | 0.309 |
HR hazards ratio; CI confidence interval
R2 value and gradient (value “q”) were calculated through trend line illustrating exponential decrease (Y = px−q). Group I is the exponential decrease group, and group II is the nonexponential decrease group. Group 1 is the exponential decrease group, group 2 is the nearly exponential decrease group, and group 3 is the randomized clearance group. The gradient (value “q”) is illustrative of the velocity of clearance